
Equimune®
Equimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the APVMA for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin.
Equimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the APVMA for the treatment of Equine Respiratory Disease Complex (ERDC) of viral origin.
Settle, mycobacterium cell wall fraction (MCWF) immunostimulant, is approved by the APVMA as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus.